Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Plos One|January 26, 2016
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3David B Shultz, Jonathan Pai, Wayland Chiu, et al.Investigational New Drugs|December 21, 2010
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancerDaniel J Renouf, Malcolm J Moore, David Hedley, et al.Acta Oncologica (Stockholm, Sweden)|September 17, 2004
Outcome and toxicity of postoperative short course adjuvant radiation and chemotherapy following resection of adenocarcinoma of the rectumJames D Brierley, Neil D'Souza, Bernard J Cummings, et al.Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.Clinical Genitourinary Cancer|September 26, 2017
Impact of Granulocyte-colony Stimulating Factor on Bleomycin-induced Pneumonitis in Chemotherapy-treated Germ Cell TumorsEdmond M Kwan, Sophie Beck, Eitan Amir, et al.Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.Cancer Chemotherapy and Pharmacology|July 6, 2010
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancerSrikala S Sridhar, Christina M Canil, Kim N Chi, et al.European Urology Oncology|July 7, 2019
Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell TumoursPeter Chung, Martin E O'Malley, Michael A S Jewett, et al.JCO Oncology Practice|March 7, 2023
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 TrialArjun Gupta, Christopher J O'Callaghan, Liting Zhu, et al.Journal of the National Cancer Institute|April 24, 2024
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17Arjun Gupta, Christopher J O'Callaghan, Liting Zhu, et al.Pageof 10